New Plain Language Summary of a Publication online!
This #accessibleresearch summary explains the results from a Phase2b RCT and its open-label extension that looked at the safety and effects of #ecopipam in children and adolescents with #Tourette syndrome:
journals.sagepub.com/doi/epdf/10....
#PLSP

Another milestone for treating TS | Tic Disorders at Washington University in St. Louis | Washington University in St. LouisWashU Medicine Top-line results were reported today for a new study in Tourette syndrome of the dopamine D1 receptor antagonist ecopipam. This was a study designed...

Exciting news about #ecopipam, a treatment being developed for #Tourette syndrome ...
... leavened with my opinion about how recent actions by the administration threaten the clinical research infrastructure for such studies.
sites.wustl.edu/tics/another...